Characterization of a caspase-cleavage resistant tau knock-in mouse
Characterization of a caspase-cleavage resistant tau knock-in mouse
批准号:
8881606
负责人:
LUCIANO D'ADAMIO
金额:
$10.29万
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-04-15 至 2015-08-31
关键词:
AdoptedAgeAlzheimer&aposs DiseaseAmyloidAmyloid beta-ProteinAmyloid beta-Protein PrecursorAmyloid depositionAnimal ModelAntibodiesAsparagineBackBehavioralBiologicalBrainC-terminalCaspaseCerebrumCleaved cellClinical TrialsCodon NucleotidesCognitive deficitsCollectionCytoskeletal ProteinsDataDefectDementiaDepositionDevelopmentDisease ProgressionExonsFailureFilamentGeneticHumanImpaired cognitionIndianaKnock-in MouseKnock-outLeadLearningLinkMediatingMemoryMemory impairmentModelingMolecularMusMutateMutationNerve DegenerationNeurodegenerative DisordersNeurofibrillary TanglesNeuronsOutcomePHF-1PathogenesisPathologyPatientsPeptidesPhysiologyPlayProcessProtein IsoformsProtein PrecursorsProteinsRegulationResistanceRoleSenile PlaquesShort-Term MemorySynapsesSynaptic plasticityTauopathiesTestingTherapeutic InterventionToxic effectTransgenic MiceTransgenic OrganismsV717Fage relatedamyloid peptideamyloid precursor protein processingbeta-site APP cleaving enzyme 1drug discoveryextracellularfamilial Alzheimer diseasefeedinginterestmouse modelmutantneurofibrillary tangle formationneuron losspresenilinpreventpromoterpublic health relevancesecretasetau Proteinstau expressiontau mutationtheoriestreatment strategy
中文摘要
描述(由申请人提供):阿尔茨海默病(AD)是世界上年龄依赖性痴呆的最常见原因,与大脑淀粉样斑块和神经纤维缠结(NFT)相关。淀粉样蛋白斑块主要由A β肽组成,而NFT由细胞骨架蛋白tau的过度磷酸化形式的异常聚集体组成。淀粉样前体蛋白(APP)的双切割产生脱乙酰肽。BACE 1裂解产生C-末端片段,β-CTF,其然后被β-分泌酶加工成几种腺苷酸同工型。遗传数据表明,APP加工的调节有助于AD。目前AD的药物发现方法集中在预防淀粉样蛋白形成或去除现有的淀粉样蛋白沉积。靶向淀粉样蛋白的化合物/生物制剂在临床试验中的反复失败可归因于纳入了疾病进展太快而无法从治疗干预中获益的AD患者,或者归因于阿尔茨海默病不是AD病理生理学的主要原因。AD的最先进的替代假设是tau毒性。与这一假设一致,降低内源性tau蛋白表达可防止表达具有家族性AD突变的人APP的转基因小鼠的行为缺陷,而不改变A β水平。我们的初步数据表明,tau还介导家族性丹麦痴呆(FDDKI小鼠)中的行为缺陷,这是一种与APP处理BRI 2/ITM 2B的调节因子突变相关的AD样痴呆,也以tau蛋白病为特征。一些证据表明,半胱天冬酶在AD进展的早期被激活,并且可能在神经元损失和NFT病理中起作用。Tau在D421处被执行人半胱天冬酶切割(Tau)。在半胱天冬酶切割后,Tau促进成核依赖性丝的形成,并采用由早期病理性tau标志物MC 1识别的构象变化。 NFT Tau可以被磷酸化并被NFT抗体PHF-1识别。在AD大脑中,Tau与NFT的标志物相关,并与认知下降相关。此外,Tau启动NFT形成并可发挥毒性作用。这些发现导致了以下假设:Tau是神经变性的关键毒性部分。为了直接测试该理论,我们已经产生了敲入小鼠,其中编码D421的外显子12中的内源性tau密码子GAC已经突变为AAC,其现在编码天冬酰胺(N)。这些被称为TauD 421 N的敲入小鼠表达tau突变体,taucas/res,其不能被半胱天冬酶切割,因此不能产生Tau Tau。TauD 421 N小鼠将用于确定在AD和FDD的动物模型中,Tau是否介导突触可塑性和记忆缺陷,AD和FDD是两种神经退行性疾病,其中tau起致病作用。我们的研究将讨论调节β-Tau形成是否是治疗AD和由神经毒性tau形式介导的其他神经退行性疾病的潜在策略。
英文摘要
DESCRIPTION (provided by applicant): Alzheimer's disease (AD) is the most common cause of ageing-dependent dementia in the world and is associated with cerebral amyloid plaques and neurofibrillary tangles (NFTs). Amyloid plaques are mostly composed of Aß peptides while NFTs are composed of abnormal aggregates of hyperphosphorylated forms of the cytoskeletal protein tau. Aß peptides are produced by a double cleavage of the amyloid precursor protein (APP). BACE1 cleavage produces the C-terminal fragment, ß-CTF, which is then processed into several Aß isoforms by -secretase. Genetic data suggest that regulation of APP processing contributes to AD. Current drug discovery approaches in AD have focused on preventing Aß formation or removing existing amyloid deposits. The repeated failures of compounds/biologics targeting amyloid in clinical trials can either be attributed to the inclusion of AD patients who were too advanced in their disease progression to benefit from therapeutic intervention, or to the fact that Aß is not the main cause of AD patho-physiology. The most advanced alternative hypothesis of AD is that of tau toxicity. Consistent with this hypothesis, reducing endogenous tau expression prevents behavioral deficits in transgenic mice expressing human APP with familial AD mutations, without altering Aß levels. Our preliminary data indicate that tau also mediates behavioral deficits in Familial Danish Dementia (FDDKI mice), an AD-like dementia associated with mutations in the regulator of APP processing BRI2/ITM2B, also characterized by tauopathy. Some evidence suggests that caspases are activated early in the progression of AD and may play a role in neuronal loss and NFT pathology. Tau is cleaved at D421 (Tau) by executioner caspases. Following caspase-cleavage, Tau facilitates nucleation-dependent filament formation and adopts a conformational change recognized by MC1, an early pathological tau marker. Tau can be phosphorylated and recognized by the NFT antibody PHF-1. In AD brains, Tau associates with markers of NFTs and correlates with cognitive decline. Furthermore, Tau initiates NFT formation and can exert toxic effects. These findings have led to the hypothesis that Tau is a critical toxic moiety underlying neurodegeneration. To directly test this theory, we have generated knock-in mice in which the endogenous tau codon GAC in exon 12, encoding for D421, has been mutated into AAC, which now encodes for an asparagine (N). These knock-in mice, called TauD421N, express a tau mutant, taucas/res that cannot be cleaved by caspases and therefore cannot generate Tau. TauD421N mice will be used to determine whether Tau mediates synaptic plasticity and memory deficits in animal models of AD and FDD, two neurodegenerative disorders in which tau plays a pathogenic role. Our studies will speak to whether modulation of Tau formation is a potential strategy for the treatment of AD and other neurodegenerative disorders mediated by neuro-toxic tau forms.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Discovery of therapeutic nanobodies targeting brain TNF-α for the treatment of Alzheimer Disease
-
批准号:10697218
-
项目类别:
-
资助金额:$49.98万
-
财政年份:2023
-
负责人:LUCIANO D'ADAMIO
-
依托单位:
Trem2-mediated microglia-neuronal axis in Alzheimer disease pathogenesis
-
批准号:10459558
-
项目类别:
-
资助金额:$78.25万
-
财政年份:2021
-
负责人:LUCIANO D'ADAMIO
-
依托单位:
Trem2-mediated microglia-neuronal axis in Alzheimer disease pathogenesis
-
批准号:10817330
-
项目类别:
-
资助金额:$78.25万
-
财政年份:2021
-
负责人:LUCIANO D'ADAMIO
-
依托单位:
Trem2-mediated microglia-neuronal axis in Alzheimer disease pathogenesis
-
批准号:10273589
-
项目类别:
-
资助金额:$78.25万
-
财政年份:2021
-
负责人:LUCIANO D'ADAMIO
-
依托单位:
Studies of dementia pathogenesis in genetically faithful rat models of Familal Alzheimer disease
-
批准号:9757536
-
项目类别:
-
资助金额:$78.7万
-
财政年份:2019
-
负责人:LUCIANO D'ADAMIO
-
依托单位:
Are mechanisms leading to FAD, SAD and age-associated cognitive decline similar?
-
批准号:10792026
-
项目类别:
-
资助金额:$179.27万
-
财政年份:2019
-
负责人:LUCIANO D'ADAMIO
-
依托单位:
Studies of dementia pathogenesis in genetically faithful rat models of Familal Alzheimer disease
-
批准号:10557185
-
项目类别:
-
资助金额:$78.7万
-
财政年份:2019
-
负责人:LUCIANO D'ADAMIO
-
依托单位:
Studies of dementia pathogenesis in genetically faithful rat models of Familal Alzheimer disease
-
批准号:9899817
-
项目类别:
-
资助金额:$78.7万
-
财政年份:2019
-
负责人:LUCIANO D'ADAMIO
-
依托单位:
Characterization of a caspase-cleavage resistant tau knock-in mouse
-
批准号:9611669
-
项目类别:
-
资助金额:$5.57万
-
财政年份:2018
-
负责人:LUCIANO D'ADAMIO
-
依托单位:
Mechanisms of APP and APLP2 function at synapses
-
批准号:9206985
-
项目类别:
-
资助金额:$71.84万
-
财政年份:2016
-
负责人:LUCIANO D'ADAMIO
-
依托单位:
Mechanisms of APP and APLP2 function at synapses
-
批准号:9053088
-
项目类别:
-
资助金额:$73.51万
-
财政年份:2016
-
负责人:LUCIANO D'ADAMIO
-
依托单位:
Characterization of a caspase-cleavage resistant tau knock-in mouse
-
批准号:9142543
-
项目类别:
-
资助金额:$14.76万
-
财政年份:2015
-
负责人:LUCIANO D'ADAMIO
-
依托单位:
Insulin/Insulin receptor modulate APP phosphorylation and dementia
-
批准号:8310436
-
项目类别:
-
资助金额:$20.84万
-
财政年份:2012
-
负责人:LUCIANO D'ADAMIO
-
依托单位:
Dissecting APP-mediated memory deficits in Danish dementia knock-in mice
-
批准号:8699627
-
项目类别:
-
资助金额:$33.99万
-
财政年份:2012
-
负责人:LUCIANO D'ADAMIO
-
依托单位:
Dissecting APP-mediated memory deficits in Danish dementia knock-in mice
-
批准号:9140943
-
项目类别:
-
资助金额:$26.86万
-
财政年份:2012
-
负责人:LUCIANO D'ADAMIO
-
依托单位:
Dissecting APP-mediated memory deficits in Danish dementia knock-in mice
-
批准号:8307589
-
项目类别:
-
资助金额:$48.57万
-
财政年份:2012
-
负责人:LUCIANO D'ADAMIO
-
依托单位:
Insulin/Insulin receptor modulate APP phosphorylation and dementia
-
批准号:8450102
-
项目类别:
-
资助金额:$23.67万
-
财政年份:2012
-
负责人:LUCIANO D'ADAMIO
-
依托单位:
Dissecting APP-mediated memory deficits in Danish dementia knock-in mice
-
批准号:8531126
-
项目类别:
-
资助金额:$33.9万
-
财政年份:2012
-
负责人:LUCIANO D'ADAMIO
-
依托单位:
BR12 Familial British and Danish Dementias and Alzheimer's Disease
-
批准号:8092680
-
项目类别:
-
资助金额:$32.38万
-
财政年份:2009
-
负责人:LUCIANO D'ADAMIO
-
依托单位:
BRI2 Familial British and Danish Dementias and Alzheimer's Disease
-
批准号:9142527
-
项目类别:
-
资助金额:$19.32万
-
财政年份:2009
-
负责人:LUCIANO D'ADAMIO
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: